Syra Health Corp. Class A Common Stock
SYRA
SYRA was delisted on the 17th of April, 2025.
9 hedge funds and large institutions have $125K invested in Syra Health Corp. Class A Common Stock in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
82% more capital invested
Capital invested by funds: $69.1K → $125K (+$56.3K)
50% more funds holding
Funds holding: 6 → 9 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.2K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$41.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$17K |
| 4 |
DLCIG
D.L. Carlson Investment Group
Concord,
New Hampshire
|
+$16.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.75K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$56K |
| 2 |
TC
Torno Capital
Cohasset,
Massachusetts
|
-$11.2K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2 |
SYRA Hedge Fund Activity: Q1 2024 in Review
9 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q1 2024, worth a combined $125K — up 82% from $69.1K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SYRA positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $55.2K. The largest seller was Walleye Capital, exiting entirely with an estimated $56K sold.
- 9 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q1 2024, up from 6 in Q4 2023.
- Funds reported $125K of Syra Health Corp. Class A Common Stock stock for Q1 2024, up 82% quarter-over-quarter.
- 6 funds opened new Syra Health Corp. Class A Common Stock positions in Q1 2024 and 3 closed out, a net change of +3 holders.
- The largest Syra Health Corp. Class A Common Stock buyer in Q1 2024 was Vanguard Group, an estimated $55.2K added.
- The largest Syra Health Corp. Class A Common Stock seller in Q1 2024 was Walleye Capital, an estimated $56K sold.
Based on aggregated 13F filings for Q1 2024.